SCHEMBL9602523

SCHEMBL9602523

O=C1CC2CSc3ccccc3C2=NN1c1cccc(O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAP3K7 O43318 1/20 0.35
TAB1 Q15750 1/20 0.35
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 1/20 0.33
ESR1 P03372 1/20 0.33
ME1 P48163 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TNNI3 P19429 1/20 0.32
HTT P42858 1/20 0.32
TNNT2 P45379 1/20 0.32
TNNC1 P63316 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10559039 0.88 KMT2A (0.44) MEN1KMT2AL3MBTL1SMN1; SMN2PDE4A
SCHEMBL9601585 0.87 MIF (0.36) MEN1KMT2ASMN1; SMN2MAP3K7TAB1
SCHEMBL10562323 0.87 PDE4A (0.40) MEN1KMT2AL3MBTL1SMN1; SMN2PDE4A
SCHEMBL10561260 0.83 ACHE (0.36) MEN1KMT2AL3MBTL1SMN1; SMN2PDE4A
SCHEMBL10561166 0.82 GAA (0.36) MEN1KMT2ASMN1; SMN2RAB9AALDH1A1
SCHEMBL10562924 0.81 CES2 (0.36) MEN1KMT2ASMN1; SMN2PDE4APDE4B
SCHEMBL10560355 0.81 HTT (0.38) MEN1KMT2ASMN1; SMN2PDE4APDE4B
SCHEMBL10564484 0.81 PRKCZ (0.40) MEN1KMT2AL3MBTL1SMN1; SMN2USP2
SCHEMBL10557556 0.81 MAPT (0.39) MEN1KMT2AL3MBTL1SMN1; SMN2PDE4A
SCHEMBL8580740 0.81 GABRP (0.43) MEN1KMT2AL3MBTL1SMN1; SMN2PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0351435-B1 FUSED PYRIDAZINE COMPOUNDS AND THEIR MEDICINAL USES Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1993-08-04 EP disclosed
US-5045541-A Immunodeficiency disorders YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1991-09-03 US disclosed